M&A Deal Summary

Sartorius Stedim Biotech Acquires Polyplus

On March 31, 2023, Sartorius Stedim Biotech acquired life science company Polyplus from ArchiMed and Warburg Pincus for 2.4B EUR

Acquisition Highlights
  • This is Sartorius Stedim Biotech’s 11th transaction in the Life Science sector.
  • This is Sartorius Stedim Biotech’s largest (disclosed) transaction.
  • This is Sartorius Stedim Biotech’s 2nd transaction in France.

M&A Deal Summary
Date 2023-03-31
Target Polyplus
Sector Life Science
Buyer(s) Sartorius Stedim Biotech
Sellers(s) ArchiMed
Warburg Pincus
Deal Type Add-on Acquisition
Deal Value 2.4B EUR
Advisor(s) Jefferies (Financial)
Kirkland & Ellis (Legal)

Target

Polyplus

Illkirch, France
website
Polyplus is a biotechnology company that supports Gene and Cell therapy, biologics manufacturing, and life science research with innovative nucleic acid transfection solutions. Polyplus was founded in 2001 and is based in Illkirch, France.

Search 192,907 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Sartorius Stedim Biotech

Aubagne, France

website

Category Company
Founded 1870
Sector Internet Software and Services
Employees8,746
Revenue 3.5B EUR (2022)
DESCRIPTION

Sartorius Stedim Biotech is a provider of cutting edge products and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, cell cultivation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. Sartorius Stedim Biotech was founded in 1870 and is based in Aubagne, France.

DEAL STATS #
Overall 19 of 19
Sector (Life Science) 11 of 11
Type (Add-on Acquisition) 13 of 13
Country (France) 2 of 2
Year (2023) 1 of 1
Size (of disclosed) 1 of 12
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-08-08 Albumedix

Nottingham, United Kingdom

Albumedix is a science-driven, albumin focused biotechnology company. Albumedix’ solutions include the world’s only USP-NF compliant recombinant human albumin (Recombumin®), client-centric development and compliance services and drug-enhancing technologies (Veltis®). Albumedix is based in Nottingham, United Kingdom.

Buy £415M

Seller(S) 2

SELLER

ArchiMed

Investor Investor Investor Investor Investor

website

Category Private Equity Firm
Founded 2014
Size Middle-Market
Type Sector Focused
DESCRIPTION

ArchiMed is a specialist French private equity firm focused on buyouts of and growth capital investments in European healthcare-oriented companies. The Firm looks to invest €5 to €300 million per transaction and specifically targets companies in the public health, care and wellness, biotech, and medical technology segments of the healthcare industry. ArchiMed was formed in 2014 and is headquartered in Lyon.

DEAL STATS #
Overall 5 of 5
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 4 of 4
Country (France) 2 of 2
Year (2023) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-08-08 Bomi Group

Spino d’Adda, Italy

Bomi Group runs cutting-edge transport, warehousing, and supply chain management services for healthcare companies ranging from pharmaceutical and medical equipment manufacturers to hospitals, testing laboratories, and outpatient service providers. Bomi Group was formed in `1985 and is based in Spino d’Adda, Italy.

Sell -
SELLER

Warburg Pincus

New York, New York, United States

Investor Investor Investor Investor Investor

website

Category Private Equity Firm
Founded 1966
PE ASSETS 83.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Warburg Pincus is a mega-sized, global private equity firm focused on investment opportunities across North America, Asia, and Europe. Warburg will consider investing at various company stages, from early-stage opportunities to distressed situations. Warburg Pincus is organized by industry groups. Verticals include financial services, healthcare, technology, media & telecommunications, energy, consumer & industrial, and real estate. Within financial services, Warburg will consider asset/wealth managers, banks, exchanges, financial technology, insurance, transaction processing, private banking, and specialty/consumer finance. Within healthcare, specific areas of interest include medical devices, healthcare services, and biotech/pharmaceuticals. Within technology/media/communications, Warburg targets software, media/internet/information, financial technology, telecom, business services, and systems/semiconductors. Within energy, specific areas of interest include oil/gas exploration, power generation/transmission, and alternative energy. Warburg Pincus raised its first fund in 1966 and is based in New York City.

DEAL STATS #
Overall 243 of 249
Sector (Life Science) 20 of 20
Type (Add-on Acquisition) 85 of 90
Country (France) 1 of 2
Year (2023) 2 of 7
Size (of disclosed) 10 of 63
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-03-09 Sand Hill Petroleum

Amsterdam, Netherlands

Sand Hill Petroleum is an exploration and production company focused on onshore conventional hydrocarbon resources in the Pannonian Basin, primarily Hungary and Romania. Sand Hill Petroleum is based in Amsterdam, Netherlands.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-04-12 Triton International

Hamilton, Bermuda

Triton International engages in the acquisition, leasing, re-leasing, and sale of various types of intermodal transportation equipment to shipping lines, and freight forwarding companies and manufacturers. Triton International was founded in 1980 and is based in Hamilton, Bermuda.

Sell $13.3B
Mergr

Product

Company

Legal